Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytokinetics (CYTK) Long-Term Investments (2016 - 2024)

Historic Long-Term Investments for Cytokinetics (CYTK) over the last 13 years, with Q3 2024 value amounting to $269.2 million.

  • Cytokinetics' Long-Term Investments rose 164016.03% to $269.2 million in Q3 2024 from the same period last year, while for Sep 2024 it was $269.2 million, marking a year-over-year increase of 164016.03%. This contributed to the annual value of $40.5 million for FY2023, which is 1321.83% down from last year.
  • Latest data reveals that Cytokinetics reported Long-Term Investments of $269.2 million as of Q3 2024, which was up 164016.03% from $305.4 million recorded in Q2 2024.
  • Over the past 5 years, Cytokinetics' Long-Term Investments peaked at $305.4 million during Q2 2024, and registered a low of $10.7 million during Q2 2022.
  • For the 5-year period, Cytokinetics' Long-Term Investments averaged around $79.0 million, with its median value being $40.5 million (2023).
  • In the last 5 years, Cytokinetics' Long-Term Investments crashed by 8551.96% in 2022 and then surged by 164016.03% in 2024.
  • Cytokinetics' Long-Term Investments (Quarter) stood at $37.0 million in 2020, then surged by 311.46% to $152.0 million in 2021, then crashed by 69.28% to $46.7 million in 2022, then dropped by 13.22% to $40.5 million in 2023, then surged by 564.05% to $269.2 million in 2024.
  • Its Long-Term Investments was $269.2 million in Q3 2024, compared to $305.4 million in Q2 2024 and $15.4 million in Q1 2024.